JCR Pharmaceuticals Co., Ltd.
TSE:4552.T
661 (JPY) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||
| Net Income
| 5,508 | 5,412 | 19,404 | 8,653 | 3,422 | 4,928 | 3,895 | 2,492.788 | 2,459.259 | 2,334.311 | 1,677.466 | 1,064.789 | 942.059 | 1,274.065 | 1,583.945 | 562.125 | 436.891 | -611.779 | 39.191 | -1,927.757 |
| Depreciation & Amortization
| 3,197 | 1,997 | 1,945 | 1,892 | 1,434 | 1,343 | 1,382 | 1,447.538 | 1,407.655 | 1,352.388 | 1,111.994 | 979.185 | 1,101.422 | 975.705 | 743.334 | 694.771 | 575.921 | 586.005 | 620.455 | 548.311 |
| Deferred Income Tax
| 0 | -9,221 | -3,074 | -983 | -1,291 | -1,310 | -145 | -1,257.009 | -392.767 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 71 | 173 | 177 | 149 | 175 | 144 | 77 | 79.352 | 85.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -3,538 | -2,956 | -9,030 | 323 | 1,398 | -1,585 | -2,391 | -208.194 | -1,631.381 | -2,178.538 | 2,298.76 | -342.734 | -2,427.864 | -1,588.763 | -619.247 | 253.968 | 626.995 | 814.079 | 759.877 | 1,412.716 |
| Accounts Receivables
| -3,390 | 4,448 | -7,402 | -205 | 857 | -1,732 | -1,378 | -374.56 | -287.706 | -1,334 | 1,031 | -851 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -2,437 | -3,877 | -1,082 | -4,699 | 258 | -157 | -1,314 | -402.918 | -947.05 | -1,292.489 | -138.811 | 95.673 | -583.94 | -574.422 | -953.587 | 112.503 | 320.124 | 294.266 | 650.514 | 2,186.355 |
| Accounts Payables
| -672 | 238 | -1,608 | 2,253 | 92 | 0 | -114 | -83.086 | 249.364 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 2,961 | -3,765 | 1,062 | 2,974 | 191 | 304 | -1,077 | 194.724 | -684.331 | -886.049 | 2,437.571 | -438.407 | -1,843.924 | -1,014.341 | 334.34 | 141.465 | 306.871 | 519.813 | 109.363 | -773.639 |
| Other Non Cash Items
| 17,038 | -905 | -133 | 307 | -211 | 385 | 315 | -1,160.138 | -119.377 | -1,009.109 | -522.859 | -39.876 | -36.727 | -679.338 | 649.505 | 314.722 | 283.707 | 341.15 | -672.95 | 608.079 |
| Operating Cash Flow
| 9,312 | -5,500 | 9,289 | 10,341 | 4,927 | 3,905 | 3,133 | 2,651.346 | 2,201.746 | 499.052 | 4,565.361 | 1,661.364 | -421.11 | -18.331 | 2,357.537 | 1,825.586 | 1,923.514 | 1,129.455 | 746.573 | 641.349 |
| Investing Activities: | ||||||||||||||||||||
| Investments In Property Plant And Equipment
| -2,095 | -8,560 | -11,333 | -7,527 | -4,838 | -895 | -999 | -1,550.607 | -1,413.936 | -1,340.279 | -2,409.604 | -1,048.012 | -292.119 | -1,152.243 | -1,922.606 | -847.141 | -2,091.556 | -2,152.396 | -166.276 | -975.967 |
| Acquisitions Net
| -600 | -6,717 | 8,167 | -2,747 | 0 | 0 | -11 | 0 | 0 | -62.664 | 64.583 | 0 | 0 | 9.633 | -6.898 | -8.888 | 901.021 | -1,177.196 | 0 | 0 |
| Purchases Of Investments
| 0 | -906 | -300 | -391 | -30 | -100 | -1,105 | -42.769 | -724.401 | -2,040.581 | -1,071.891 | -308.313 | -528.452 | -1,326.246 | -3,231.253 | -2,095.427 | -1,749.774 | -4,415.732 | -52.383 | -143.446 |
| Sales Maturities Of Investments
| 0 | 259 | 300 | 584 | 798 | 1,257 | 450 | 736.326 | 1,182.94 | 1,957.591 | 750.178 | 1,150.537 | 1,906.834 | 421.891 | 1,429.641 | 2,700 | 1,100 | 1,177.71 | 397.482 | 0 |
| Other Investing Activites
| 5 | 922 | -84 | 6,791 | -91 | -22 | 78 | 15.647 | -25.202 | -59.057 | 63.032 | 27.323 | 453.425 | -155.193 | 334.376 | 49.338 | 823.812 | -1,221.284 | -45.742 | -114.277 |
| Investing Cash Flow
| -2,690 | -15,002 | -3,250 | -3,290 | -4,161 | 240 | -1,587 | -841.403 | -980.599 | -1,419.662 | -2,668.285 | -178.465 | 1,539.688 | -2,211.791 | -3,396.74 | 121.821 | -571.518 | -4,634.506 | 133.081 | -1,233.69 |
| Financing Activities: | ||||||||||||||||||||
| Debt Repayment
| -500 | -3,050 | -750 | -650 | -850 | -413 | -233 | -550.28 | -759.46 | -665.26 | -580.6 | -430.8 | -468 | -666.4 | -731.6 | -367.2 | -985.811 | -485.445 | -817.196 | -1,899.73 |
| Common Stock Issued
| 15 | 7,728 | 740 | 10,023 | 3,874 | 387 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,256.462 | 0 | 0 | 3,875.616 | 0 | 0 |
| Common Stock Repurchased
| 15 | 10 | 10 | 13 | 15 | 26 | -2,585 | -743.545 | -205.214 | 40 | 27 | 42 | 0 | 0 | 537.697 | 0 | 0 | 1,409.648 | 0 | 0 |
| Dividends Paid
| -2,500 | -2,739 | -2,169 | -1,083 | -989 | -834 | -748 | -699.277 | -640.032 | -592.414 | -412.511 | -382.196 | -385.81 | -485.595 | -253.234 | -270.194 | -273.296 | -268.055 | -242.095 | -234.006 |
| Other Financing Activities
| -46 | -1 | -10 | 1 | -2 | -83 | -1,194 | 1,395.859 | 85.468 | -3.686 | 623.661 | 574.923 | -211.508 | -124.543 | 484.749 | -638.834 | 746.937 | 1,409.037 | -48.528 | 3,814.364 |
| Financing Cash Flow
| -2,031 | 1,948 | -2,179 | 8,304 | 2,048 | -917 | -2,175 | 146.302 | -1,314.024 | -1,261.36 | -369.45 | -238.073 | -1,065.318 | -1,276.538 | 1,756.377 | -1,276.228 | -512.17 | 4,531.153 | -1,107.819 | 1,680.628 |
| Other Information: | ||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 886 | 1,099 | 612 | -22 | 20 | 12 | 14 | -15.037 | -27.149 | 44.302 | 104.446 | 38.971 | -0.297 | -15.634 | -3.259 | -35.443 | -16.34 | 10.912 | 16.046 | 4.762 |
| Net Change In Cash
| 5,478 | -17,455 | 4,473 | 15,332 | 2,837 | 3,241 | -614 | 1,941.208 | -120.027 | -2,137.669 | 1,632.071 | 1,283.796 | 52.962 | -3,522.296 | 713.916 | 635.735 | 823.485 | 1,037.016 | -212.118 | 1,093.049 |
| Cash At End Of Period
| 18,756 | 13,278 | 30,733 | 26,260 | 10,928 | 8,091 | 4,850 | 5,464.484 | 3,523.276 | 3,643.303 | 5,780.972 | 4,148.901 | 2,865.105 | 2,812.143 | 6,334.439 | 5,620.523 | 4,984.788 | 4,161.303 | 3,124.287 | 3,336.405 |